Shares of health-care companies were flat as traders rotated into more economically sensitive areas in light of growth and interest-rate outlooks.
Continue Reading Below
Johnson & Johnson's Animas Corp. unit is set to close and exit the insulin pump business, the company said, citing increased competition that made selling the pumps unsustainable.
Rob Curran, email@example.com
(END) Dow Jones Newswires
October 05, 2017 17:17 ET (21:17 GMT)